Physician profile
Allison M Murphy
NPI 1962744060
$2,596.84
in general payments reported to CMS, 2019-2025
30 companies · $504 in 2025
The $504 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $107 · 2021: $498 · 2022: $438 · 2023: $506 · 2024: $431 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $376.47 | 2021-2025 | |
| Abbvie INC. | $370.92 | 2019-2025 | |
| Biogen, INC. | $161.13 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $152.12 | 2023-2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $146.67 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $143.62 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $120.95 | 2021-2025 | Slynd |
| Organon LLC | $120.54 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $117.23 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $116.43 | 2019-2022 | |
| Hologic Sales and Service, LLC | $110.73 | 2021-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Gynesonics, INC. | $83.41 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Minerva Surgical, INC | $75.66 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.43 | 2021-2025 | |
| Mylan Pharmaceuticals INC. | $49.95 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $48.96 | 2021 | |
| Allergan, INC. | $47.93 | 2019-2020 | |
| Millicent US INC | $43.07 | 2025 | Intrarosa, Femlyv |
| Pacira Pharmaceuticals Incorporated | $39.74 | 2024 | Iovera, Zilretta, Exparel |
| Merck Sharp & Dohme LLC | $31.79 | 2021-2025 | Bridion |
| Becton, Dickinson and Company | $21.00 | 2024 | Bd Onclarity |
| Myovant Sciences INC. | $20.66 | 2021 | |
| Sumitomo Pharma America, INC. | $17.61 | 2025 | Myfembree |
| Medicem INC. | $17.48 | 2022 | |
| Evofem Biosciences, INC. | $17.45 | 2021 | |
| Optumhealth Care Solutions, LLC | $16.58 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Smith+Nephew, INC. | $15.00 | 2024 | Pico 7 |
| Shield Therapeutics INC | $14.91 | 2025 | |
| Pfizer INC. | $12.11 | 2021 | |
| Meditrina | $11.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.